Fed. Circ. Probes If Galderma Bound By Statements To PTAB
The Federal Circuit wrestled Thursday with whether arguments Galderma made in the process of persuading the Patent Trial and Appeal Board to uphold patents on its rosacea drug Oracea can be...To view the full article, register now.
Already a subscriber? Click here to view full article